Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Sign Up
Cited by 212

The DOI matches its Crossref record.

The Athlete Biological Passport

Sottas, Pierre-Edouard, Robinson, Neil, Rabin, Olivier, Saugy, Martial·2011·Clinical Chemistry
DOI 10.1373/clinchem.2011.162271
Open this paper in CoChat — free account

Abstract

BACKGROUND: In elite sports, the growing availability of doping substances identical to those naturally produced by the human body seriously limits the ability of drug-testing regimes to ensure fairness and protection of health. CONTENT: The Athlete Biological Passport (ABP), the new paradigm in testing based on the personalized monitoring of biomarkers of doping, offers the enormous advantage of being independent of this endless pharmaceutical race. Doping triggers physiological changes that provide physiological enhancements. In the same way that disease-related biomarkers are invaluable tools that assist physicians in the diagnosis of pathology, specifically selected biomarkers can be used to detect doping. SUMMARY: The ABP is a new testing paradigm with immense potential value in the current climate of rapid advancement in biomarker discovery. In addition to its original aim of providing proof of a doping offense, the ABP can also serve as a platform for a Rule of Sport, with the presentation before competition of the ABP to objectively demonstrate that the athlete will participate in a healthy physiological condition that is unaltered by performance-enhancing drugs. Finally, the decision-support system used today for the biological monitoring of world top-level athletes can also be advantageously transferred to other areas of clinical practice to reach the goal of personalized medicine.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1373/clinchem.2011.162271

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

No references could be resolved yet.

Research works printed but not linked: 32

  1. Thevis, 2010, Mass spectrometry in sports drug testing: structure characterization and analytical assays, Mass Spectrom Rev, 26, 79, 10.1002/mas.20107 · DOI
  2. Macdougall, 2009, Current and upcoming erythropoiesis-stimulating agents, iron products, and other novel anemia medications, Adv Chronic Kidney Dis, 16, 117, 10.1053/j.ackd.2008.12.010 · DOI
  3. Donike, 1983, Nachweis von exogenem Testosterone, 293
  4. Oftebro, 1992, Evaluating an abnormal urinary steroid profile, Lancet, 339, 941, 10.1016/0140-6736(92)90994-E · DOI
  5. Schulze, 2009, Genetic variation in androgen disposition: implications in clinical medicine including testosterone abuse, Expert Opin Drug Metab Toxicol, 5, 731, 10.1517/17425250902976862 · DOI
  6. Sottas, 2010, Endogenous steroid profiling in the Athlete Biological Passport, Endocrinol Metab Clin North Am, 39, 59, 10.1016/j.ecl.2009.11.003 · DOI
  7. Handelsman, 2008, Indirect androgen doping by oestrogen blockade in sports, Br J Pharmacol, 154, 598, 10.1038/bjp.2008.150 · DOI
  8. Robinson, 2005, Haematological analysis conducted at the departure of the Tour de France 2001, Int J Sports Med, 26, 200, 10.1055/s-2004-830495 · DOI
  9. Gore, 2003, Second-generation blood tests to detect erythropoietin abuse by athletes, Haematologica, 88, 333
  10. Sottas, 2006, Statistical classification of abnormal blood profiles in athletes, Int J Biostatistics, 2, 3, 10.2202/1557-4679.1011 · DOI
  11. WHO., 2001, Iron deficiency anemia: assessment, prevention and control: a guide for programme managers, 114
  12. Sharpe, 2002, et al. Development of reference ranges in elite athletes for markers of altered erythropoiesis, Haematologica, 87, 1248
  13. Robinson, 2007, Bayesian detection of abnormal hematological values to introduce a no-start rule for heterogeneous populations of athletes, Haematologica, 92, 1143, 10.3324/haematol.11182 · DOI
  14. Sottas, 2008, A forensic approach to the interpretation of blood doping markers, Law Prob Risk, 7, 191, 10.1093/lpr/mgm042 · DOI
  15. Sharpe, 2006, A third generation approach to detect erythropoietin abuse in athletes, Haematologica, 91, 356
  16. Sottas, 2007, Bayesian detection of abnormal values in longitudinal biomarkers with an application to T/E ratio, Biostatistics, 2, 285, 10.1093/biostatistics/kxl009 · DOI
  17. Sottas, 2008, From population- to subject-based limits of T/E ratio to detect testosterone abuse in elite sports, For Sci Int, 174, 166
  18. Cazzola, 2000, A global strategy for prevention and detection of blood doping with erythropoietin and related drugs, Haematologica, 85, 561
  19. Ashenden, 2002, A strategy to deter blood doping in sport, Haematologica, 87, 225
  20. Malcovati, 2003, Hematologic passport for athletes competing in endurance sports: a feasibility study, Haematologica, 88, 570
  21. Sottas, 2010, The athlete’s biological passport and indirect markers of blood doping, Handb Exp Pharmacol, 195, 305, 10.1007/978-3-540-79088-4_14 · DOI
  22. WADA., 2009, Athlete Biological Passport operating guidelines and compilation of required elements
  23. Holt, 2008, Growth hormone, IGF-I and insulin and their abuse in sport, Br J Pharmacol, 154, 542, 10.1038/bjp.2008.99 · DOI
  24. Liotta, 2003, Clinical proteomics: written in blood, Nature, 425, 905, 10.1038/425905a · DOI
  25. Saks, 2005, The coming paradigm shift in forensic identification science, Science (Wash DC), 309, 892, 10.1126/science.1111565 · DOI
  26. Lamon, 2010, IEF pattern classification-derived criteria for the identification of epoetin-delta in urine, Electrophoresis, 31, 1918, 10.1002/elps.200900645 · DOI
  27. Schulze, 2009, Substantial advantage of a combined Bayesian and genotyping approach in testosterone doping tests, Steroids, 74, 365, 10.1016/j.steroids.2008.11.003 · DOI
  28. Schumacher, 2009, Performance profiling: a role for sport science in the fight against doping?, Int J Sports Physiol Perform, 4, 129, 10.1123/ijspp.4.1.129 · DOI
  29. Cantor, 2009, Enabling personalized medicine through the use of healthcare information technology, Personalized Medicine, 6, 589, 10.2217/pme.09.35 · DOI
  30. Berry, 2006, Bayesian clinical trials, Nat Rev Drug Discov, 5, 27, 10.1038/nrd1927 · DOI
  31. Taroni, 2006, Bayesian Networks and Probabilistic Inference in Forensic Science, 372, 10.1002/0470091754 · DOI
  32. Xue, 2008, Adaptive evolution of UGT2B17 copy-number variation, Am J Hum Genet, 83, 337, 10.1016/j.ajhg.2008.08.004 · DOI

Cited by

See all 212

Metadata

Authors
Sottas, P.-E., Robinson, N., Rabin, O., & Saugy, M.
Affiliations
  • Swiss Laboratory for Anti-Doping Analyses, Chemin des Croisettes, 1066 Lausanne, Switzerland
  • World Anti-Doping Agency, Montreal, Canada
Venue
Clinical Chemistry
Publisher
Oxford University Press (OUP)
Published
2011-07-01
Volume
57
Issue
7
Pages
969-976
ISSN
  • 0009-9147
  • 1530-8561
DOI
10.1373/clinchem.2011.162271
Cited by
212
References
0
Language
en
Licence
academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model (vor)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The Athlete Biological Passport. https://app.cochat.ai/papers/10.1373/clinchem.2011.162271
The paper
Sottas, P.-E., Robinson, N., Rabin, O., & Saugy, M. (2011). The Athlete Biological Passport. Clinical Chemistry. https://doi.org/10.1373/clinchem.2011.162271

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.